Pharma stocks rise as Cipla faces supply issues, Zydus gains FDA approval, and Biocon secures funding through a QIP.

Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars ...

Indian drugmaker Biocon Ltd. drew demand for about four times the shares it offered to institutional investors, with interest largely coming from local mutual funds, according to people familiar with ...

This floor price is at a premium to the stock's recent performance. On Monday, shares of Biocon settled 2 per cent lower at ...

Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the ...

Biocon Ltd is quoting at Rs 383.95, up 1.31% on the day as on 12:49 IST on the NSE. The stock is down 2.48% in last one year as compared to a 11% jump in NIFTY and a 1.13% jump in the Nifty Pharma ...

Stocks to Watch today, January 7, 2026: Indian equities are expected to open lower on Wednesday, tracking mixed global cues.

The board of Biocon has approved the issue of 11.26 crore equity shares of face value of ₹5 each to eligible institutions.

Track top stocks like TCS, HCL Tech, Biocon, and Maruti Suzuki after fresh earnings and deals—get the latest market movers ...

Stocks including TCS, Adani Energy Solutions, Anand Rathi Wealth, HCL Technologies, Biocon, NBCC, NLC India, KRBL and more ...

Sical Logistics Ltd., KP Energy Ltd., Mazagon Dock Shipbuilders Ltd., Biocon Ltd. and ICICI Lombard General Insurance Co. are ...

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg ...